Bayer And Evotec Partner To Develop New Treatments To Fight Kidney Diseases

Bayer and Evotec have entered into a five-year, multi-target research partnership to develop multiple clinical candidates for the treatment of kidney diseases such as chronic kidney disease in diabetes patients. Both companies will contribute novel drug targets and a comprehensive set of high-quality technology platforms to jointly develop innovative treatment options for these severe conditions. The partners will share responsibilities during pre-clinical development of potential clinical candidates.

URL:
www.prnewswire.com/news-releases/bayer-and-evotec-partner-to-develop-new-treatments-to-fight-kidney-diseases-300329251.html